Search Results 1-10 of 16948 for nivolumab

1. Nivolumab (intravenous route) - Side effects & uses - Mayo Clinic

   Brand Name. US Brand Name · Description. Nivolumab injection is used alone or together with other medicines (eg, ipilimumab) to treat melanoma (skin cancer) that ...

2. Nivolumab/relatlimab-rmbw (intravenous route) - Side effects & uses - Mayo Clinic

   Description. Nivolumab and relatlimab-rmbw combination injection is used to treat melanoma (skin cancer) that has spread throughout the body (metastatic) or ...

3. Nivolumab and hyaluronidase-nvhy (subcutaneous route) - Side effects & uses - Mayo Clinic

   Nivolumab is a monoclonal antibody that affects the immune system and helps control the growth of cancer cells. This medicine is to be given only by or under ...

4. Nivolumab shows significant benefit for Hodgkin’s lymphoma in Mayo Clinic co-led phase I study

   — A phase I clinical trial of nivolumab found that the immune-boosting drug is a highly effective therapy for Hodgkin's lymphoma. The multi-institution study, ...

5. Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer - Mayo Clinic

   Monoclonal antibodies, such as nivolumab, may stimulate the immune system in different ways and kill tumor cells remaining after surgery and standard of care ...

6. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

7. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

8. A Study of the Safety and Effectiveness of Nivolumab for the Treatment of Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   The purpose of this study is to determine whether nivolumab alone or in combination with standard of care therapies will provide clinical benefit without ...

9. An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d or Stage IV Melanoma - Mayo Clinic

   An Investigational Immuno-therapy Study of Nivolumab Combined With Ipilimumab Compared to Nivolumab by Itself After Complete Surgical Removal of Stage IIIb/c/d ...

10. A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Complete Resection - Mayo Clinic

    The purpose of this study is to compare the drug levels of nivolumab administered subcutaneously versus intravenous administration in participants with melanoma ...